VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

ArkVax

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 77 out of 100

Combatting Antimicrobial Resistance via a Novel Vaccine Technology

  • Agtech
  • Biotech & therapeutics
Status
Operatingas of 2026-09-17
Business model
B2B
Legal name
ArkVax
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

ArkVax specializes in developing glycoconjugate vaccines. These have the potential to transform animal health by offering greater potency and broader protection than current vaccines. ArkVax’s vaccines also have the potential to combat antimicrobial resistance in animal but also humans by conferring protection from zoonotic diseases.

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy